Peginterferon lambda for the treatment of hospitalized patients with mild COVID-19: A pilot phase 2 randomized placebo-controlled trial

Peginterferon lambda for the treatment of hospitalized patients with mild COVID-19: A pilot phase 2 randomized placebo-controlled trial

BackgroundThis study aimed to investigate the efficacy and safety of subcutaneous injection of peginterferon lambda in patients hospitalized with COVID-19.MethodsIn this study (NCT04343976), patients admitted to hospital with COVID-19 confirmed by RT-PCR from nasopharyngeal swab were randomly assign...

Full description

Bibliographic Details
Main Authors: Myung-Ho Kim, Josh Elbaz, Nikolaus Jilg, Jenna L. Gustafson, Min Xu, Dilara Hatipoglu, Eric Nohelty, Arthur Y. Kim, Raymond T. Chung
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Medicine
Subjects:
COVID-19
peginterferon lambda
SARS-CoV-2 viral load
IP-10 (CXCL-10)
CXCL9
(C-X-C motif) ligand 9
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1095828/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2023.1095828/full

Similar Items